Literature DB >> 20219799

Withdrawal of sibutramine. Editorial is judgment in advance of the facts.

Nick Finer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20219799     DOI： 10.1136/bmj.c1346

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Laboratory animals as surrogate models of human obesity.

Authors:  Cecilia Nilsson; Kirsten Raun; Fei-fei Yan; Marianne O Larsen; Mads Tang-Christensen
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

2.  Controversy about the cardiovascular safety of sibutramine.

Authors:  André J Scheen
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

3.  Drug treatment for obesity in the post-sibutramine era.

Authors:  Bernard M Y Cheung
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

4.  Lifestyle modification in the management of the metabolic syndrome: achievements and challenges.

Authors:  Riccardo Dalle Grave; Simona Calugi; Elena Centis; Rebecca Marzocchi; Marwan El Ghoch; Giulio Marchesini
Journal:  Diabetes Metab Syndr Obes       Date:  2010-11-02       Impact factor: 3.168
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.